4.8 Review

Allosteric Mechanisms of Molecular Machines at the Membrane: Transport by Sodium-Coupled Symporters

期刊

CHEMICAL REVIEWS
卷 116, 期 11, 页码 6552-6587

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrev.5b00627

关键词

-

资金

  1. NIH [P01 DA012408, R01 DA035263, R01 DA015170, R01 DA017293, U54 GM087519]
  2. Ruth L. Kirschstein National Research Service Award [F31 DA035533]
  3. Texas Advanced Computing Center at the University of Texas at Austin [TG-MCB090132, TG-MCB120008]
  4. Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725, DE-AC02-05CH11231]
  5. [PSCA14026P]

向作者/读者索取更多资源

Solute transport across, cell membranes is ubiquitous in biology as an essential physiological process. Secondary active transporters couple the unfavorable process of solute transport against its concentration gradient to the energetically favorable transport: of one or several ions. The study of such transporters Over several decades indicates that their function involves complex allosteric mechanisms that are progressively being-revealed in atomistic detail. We focus on two well-characterized sodium-coupled symporters: the bacterial amino acid transporter LeuT, which is the prototype for the gated pore mechanism in the mammalian synaptic monoamine transporters, and the archaeal GltPh, which is the prototype for the elevator mechanism in the mammalian excitatory amino acid transporters. We present the evidence for the role of allostery in the context of a quantitative formalism that can reconcile biochemical and biophysical data and thereby connects directly to recent insights into the molecular structure and dynamics of these proteins. We demonstrate that, while the structures and mechanisms of these transporters are very different, the available data suggest a common role of specific models of allostery in their functions. We argue that such allosteric mechanisms appear essential not only for sodium-coupled symport in general but also for the function of other types of molecular machines in the membrane.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Computer Science, Interdisciplinary Applications

A lightweight method for evaluating in situ workflow efficiency

Tu Mai Anh Do, Loic Pottier, Silvina Caino-Lores, Rafael Ferreira da Silva, Michel A. Cuendet, Harel Weinstein, Trilce Estrada, Michela Taufer, Ewa Deelman

Summary: Performance evaluation is crucial for understanding the behavior of scientific workflows, especially in dealing with in situ workflows. By proposing a lightweight metric, the resource usage efficiency of in situ workflow execution can be assessed, analyzing the tradeoffs of various configurable parameters and evaluating different execution scenarios.

JOURNAL OF COMPUTATIONAL SCIENCE (2021)

Article Biophysics

Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide

George Khelashvili, Ambrose Plante, Milka Doktorova, Harel Weinstein

Summary: Studies have shown that the fusion peptide (FP) of coronaviruses requires binding of Ca2+ ions to enhance penetration, but the mechanisms of membrane insertion and destabilization remain unclear.

BIOPHYSICAL JOURNAL (2021)

Article Biochemical Research Methods

A Graphic Encoding Method for Quantitative Classification of Protein Structure and Representation of Conformational Changes

Hector Carrillo-Cabada, Jeremy Benson, Asghar M. Razavi, Brianna Mulligan, Michel A. Cuendet, Harel Weinstein, Michela Taufer, Trilce Estrada

Summary: To successfully predict a protein's function, techniques that maintain its 3D information while performing at scale are necessary. Researchers extended a protein representation and neural network architecture, demonstrating applicability in protein function prediction and detection of conformational changes in protein trajectories.

IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2021)

Article Biochemistry & Molecular Biology

Ligand-Dependent Conformational Transitions in Molecular Dynamics Trajectories of GPCRs Revealed by a New Machine Learning Rare Event Detection Protocol

Ambrose Plante, Harel Weinstein

Summary: Molecular Dynamics (MD) simulations are vital tools for ligand discovery and design, but the challenges of handling large datasets and rare events in complex molecular machines remain. A protocol called Rare Event Detection (RED) has been developed to efficiently detect functionally relevant responses to ligand binding, offering new insights into drug activity.

MOLECULES (2021)

Article Multidisciplinary Sciences

Localization atomic force microscopy

George R. Heath, Ekaterina Kots, Janice L. Robertson, Shifra Lansky, George Khelashvili, Harel Weinstein, Simon Scheuring

Summary: This study introduces a new technique called localization AFM (LAFM) that overcomes traditional AFM resolution limits by applying localization image reconstruction algorithms, allowing for structural analysis of biomolecules at the single-molecule level.

NATURE (2021)

Correction Multidisciplinary Sciences

Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption (vol 12, 5910, 2021)

David Froelicher, Juan R. Troncoso-Pastoriza, Jean Louis Raisaro, Michel A. Cuendet, Joao Sa Sousa, Hyunghoon Cho, Bonnie Berger, Jacques Fellay, Jean-Pierre Hubaux

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption

David Froelicher, Juan R. Troncoso-Pastoriza, Jean Louis Raisaro, Michel A. Cuendet, Joao Sa Sousa, Hyunghoon Cho, Bonnie Berger, Jacques Fellay, Jean-Pierre Hubaux

Summary: The authors propose a federated analytics system based on multiparty homomorphic encryption to protect patient privacy and ensure accurate results in biomedical research. They demonstrate the system's effectiveness in various essential biomedical analysis tasks. This work represents a key step towards enabling multi-centric scientific collaborations and overcoming privacy obstacles.

NATURE COMMUNICATIONS (2021)

Article Oncology

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma

Veronica Aedo-Lopez, Camille L. Gerard, Sarah Boughdad, Bianca Gautron Moura, Gregoire Berthod, Antonia Digklia, Krisztian Homicsko, Niklaus Schaefer, Rafael Duran, Michel A. Cuendet, Olivier Michielin

Summary: This retrospective study evaluated the safety and efficacy of sequential treatment with Ipilimumab plus Nivolumab and selective internal radiation therapy (SIRT) in patients with metastatic uveal melanoma. The results showed that this treatment approach is well-tolerated and has promising survival rates.

CANCERS (2022)

Article Oncology

Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma

Bianca Gautron Moura, Camille L. Gerard, Nathalie Testart, Marian Caikovski, Alexandre Wicky, Veronica Aedo-Lopez, Gregoire Berthod, Krisztian Homicsko, John O. Prior, Clarisse Dromain, Lana E. Kandalaft, Michel A. Cuendet, Olivier Michielin

Summary: In stage IV melanoma, the combination of ipilimumab and nivolumab significantly improves outcomes but has a major financial impact on healthcare. This study analyzes the costs associated with ipilimumab-nivolumab combination, focusing on immune-related adverse events (irAE). Surprisingly, toxicity costs are insignificant compared to the total treatment costs, and patients with higher toxicity grades have lower costs and better outcomes. These findings provide important information for clinicians and healthcare organizations making treatment decisions in immunotherapy.

CANCERS (2023)

Article Oncology

A differential process mining analysis of COVID-19 management for cancer patients

Michel A. Cuendet, Roberto Gatta, Alexandre Wicky, Camille L. Gerard, Margaux Dalla-Vale, Erica Tavazzi, Gregoire Michielin, Julie Delyon, Nabila Ferahta, Julien Cesbron, Sebastien Lofek, Alexandre Huber, Jeremy Jankovic, Rita Demicheli, Hasna Bouchaab, Antonia Digklia, Michel Obeid, Solange Peters, Manuela Eicher, Sylvain Pradervand, Olivier Michielin

Summary: This study utilized Process Mining to analyze the therapeutic pathways of cancer patients following COVID-19 infection, introducing Differential Process Mining tool to compare patient strata and quantify hospital adaptation to the pandemic, as well as to understand the impact of cancer and its treatment on COVID-19 outcomes.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Interactive process mining of cancer treatment sequences with melanoma real-world data

Alexandre Wicky, Roberto Gatta, Sofiya Latifyan, Rita De Micheli, Camille Gerard, Sylvain Pradervand, Olivier Michielin, Michel A. Cuendet

Summary: The increasing availability of clinical real-world data (RWD) provides an opportunity to supplement evidence from randomized clinical trials and explore treatment outcomes in real-life conditions. Process mining is a suitable methodology for analyzing treatment paths and outcomes. In this study, an interactive application was implemented to compare treatment sequences based on overall survival, progression-free survival, and best overall response. The application was used to conduct a descriptive analysis of RWD in advanced melanoma patients and explore the outcomes of different treatment choices. Results showed long-term survival benefits from immune-checkpoint inhibitors rechallenge, suggesting potential implications for treatment guidelines.

FRONTIERS IN ONCOLOGY (2023)

Article Health Care Sciences & Services

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

Andre Manuel da Silva Lopes, Sara Colomer-Lahiguera, Celia Darnac, Stellio Giacomini, Sebastien Bugeia, Garance Gutknecht, Gilliosa Spurrier-Bernard, Michel Cuendet, Fanny Muet, Veronica Aedo-Lopez, Nuria Mederos, Olivier Michielin, Alfredo Addeo, Sofiya Latifyan, Manuela Eicher

Summary: This study aims to shorten the time between symptomatic immune-related adverse events (IrAEs) onset and clinician detection through remote patient monitoring and symptom management. The study plans to recruit 198 cancer patients receiving immune checkpoint inhibitors (ICIs) and randomize them into an intervention group and a control group. The results will make a significant impact on the routine care of patients treated with ICIs.

JMIR RESEARCH PROTOCOLS (2023)

Article Oncology

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anais Elewaut, Camille L. Gerard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Krecioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Ines Pires da Silva, Harriet Witthock, Michel A. Cuendet, Sebastian Carotta, Kevin J. Harrington, Johannes Zuber, Richard A. Scolyer, Georgina Long, James S. Wilmott, Olivier Michielin, Sakari Vanharanta, Thomas Wiesner, Anna C. Obenauf

Summary: The study reveals that tumors relapsing after targeted therapy show cross-resistance to immunotherapies due to an immunosuppressive tumor microenvironment lacking CD103(+) dendritic cells. Cross-resistance is not a result of immune response pressure during resistance evolution, but stems from the MAPK pathway's increased transcriptional output driving immune evasion. Restoring CD103(+) dendritic cells can resensitize tumors to immunotherapy.

NATURE CANCER (2021)

暂无数据